MCM
NVCR icon

MV Capital Management’s NovoCure NVCR Stock Holding History

MV Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14
Closed -$250 – 1097
2025
Q2 		$250 Hold
14
– – ﹤0.01% 922
2025
Q1 		$250 Hold
14
– – ﹤0.01% 902
2024
Q4 		$418 Hold
14
– – ﹤0.01% 834
2024
Q3 		$219 Hold
14
– – ﹤0.01% 886
2024
Q2 		$240 Buy
+14
New +$246 ﹤0.01% 782
2022
Q1 		– Sell
-200
Closed -$15K – 700
2021
Q4 		$15K Hold
200
– – ﹤0.01% 366
2021
Q3 		$23K Hold
200
– – ﹤0.01% 291
2021
Q2 		$44K Buy
+200
New +$38.9K 0.01% 202

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MV Capital Management's NVCR Position: Q3 2025 in Review

MV Capital Management sold out of NovoCure (NVCR) in Q3 2025, closing a stake of 14 shares — an estimated $250 sold.

MV Capital Management first reported a position in NVCR in Q2 2021 and held it in 8 quarters. The position peaked at $44K in Q2 2021. 244 funds tracked by Wall St. Rank hold NVCR as of Q3 2025.

  • MV Capital Management reported no remaining NovoCure position as of Q3 2025 after selling out during the quarter.
  • MV Capital Management sold 14 NovoCure shares in Q3 2025, an estimated $250.
  • MV Capital Management first reported a position in NovoCure in Q2 2021 and held it in 8 quarters.
  • MV Capital Management's NovoCure position peaked at $44K in Q2 2021.
  • 244 funds tracked by Wall St. Rank held NovoCure as of Q3 2025.

Based on MV Capital Management's 13F filing for Q3 2025, filed 23 Feb 2026.